Chemistry: analytical and immunological testing – Clotting or clotting factor level tests
Patent
1988-05-27
1992-10-20
Housel, James C.
Chemistry: analytical and immunological testing
Clotting or clotting factor level tests
436171, 436805, 435 4, 435 13, 73 6443, 36441309, 356 39, G01N 3386
Patent
active
051569744
ABSTRACT:
A method for determining the fibrinogen level of a patient blood plasma in an optical density based prothrombin time test. The method and apparatus utilize a novel parameter DELTA which factors out statistical inaccuracies associated with prior art test methods. The patient fibrinogen level is determined using DELTA points calculated from blood samples having known fibrinogen levels in the low, normal and high ranges. A piece wise function is then constructed around the DELTA points and the fibrinogen level of a patient blood sample is calculated using four equations pre-stored in a non-volatile memory.
REFERENCES:
patent: 3307392 (1967-03-01), Owen et al.
patent: 3458287 (1969-07-01), Gross et al.
patent: 4047890 (1977-07-01), Eichelberger et al.
patent: 4289498 (1981-07-01), Baughman et al.
Grossman Hyman
Rausch Michael
Biodata Corporation
Housel James C.
Redding David
LandOfFree
Method for determining the fibrinogen level of a blood sample does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the fibrinogen level of a blood sample, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the fibrinogen level of a blood sample will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-191545